Pharmacology, Toxicology and Pharmaceutical Science
Glioblastoma
100%
Antiangiogenic Therapy
100%
Activin
100%
Bevacizumab
80%
Therapy Resistance
40%
Activin A
40%
Inhibitor of Differentiation 1
40%
Neoplasm
20%
Carcinogenesis
20%
Cytokine
20%
Long Term Exposure
20%
Mouse Model
20%
4 [4 (1,3 Benzodioxol 5 Yl) 5 (2 Pyridinyl) 1h Imidazol 2 Yl]benzamide
20%
Immunology and Microbiology
Vascularization
100%
Antiangiogenic Activity
100%
Activin
100%
Bevacizumab
80%
Activin A
40%
Inhibitor of Differentiation 1
40%
Cytokine
20%
Mouse Model
20%
Biochemistry, Genetics and Molecular Biology
Vascularization
100%
Activin
100%
Antiangiogenic Activity
100%
Bevacizumab
80%
Inhibitor of Differentiation 1
40%
Carcinogenesis
20%
Cytokine
20%
Mouse Model
20%
Neuroscience
Angiogenesis
100%
Activin
100%
Bevacizumab
80%
Activin A
40%
Inhibitor of Differentiation 1
40%
Carcinogenesis
20%